@longevitytech.bsky.socialBoehringer Ingelheim widens its kidney-disease partnership to cardiovascular targets, in a deal that could exceed $250 million.
Link as first comment.
#longevity #boehringeringelheim #kidneydisease #cardiovascular #partnership
@4040rec.bsky.social
@cio-magazin.bsky.socialMit dem explorativen Digitallabor BI X hebt man sich bei Boehringer Ingelheim bewusst von traditionellen Strukturen ab: Chaos ist Trumpf. www.cio.de/article/4225... #boehringeringelheim #innovation #idee #inkubator #KI
@nordic.skyen.live🇩🇰 Flåtsæsonen varer i efteråret pga. mildt vejr
@pharmaphorum.bsky.socialGenerating good-quality #patientexperiencedata (PED) is becoming increasingly important for #medicinedevelopment, and #BoehringerIngelheim has launched a hub to help #patientorganisations gather it effectively.
@axonvet.bsky.social#axónvet #informaciónveterinaria #saludanimal #premio #BoehringerIngelheim
@pharmaphorum.bsky.social#BoehringerIngelheim has joined Sanofi and AstraZeneca in signing up to deploy #Owkin's #AI platform #KPro in its #drugdiscovery operations.